These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 25941633)
1. Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain. Hijikata A; Yura K; Ohara O; Go M Meta Gene; 2015 Jun; 4():92-106. PubMed ID: 25941633 [TBL] [Abstract][Full Text] [Related]
2. Tafazzin splice variants and mutations in Barth syndrome. Kirwin SM; Manolakos A; Barnett SS; Gonzalez IL Mol Genet Metab; 2014 Jan; 111(1):26-32. PubMed ID: 24342716 [TBL] [Abstract][Full Text] [Related]
4. AAV9- Suzuki-Hatano S; Saha M; Soustek MS; Kang PB; Byrne BJ; Cade WT; Pacak CA Mol Ther Methods Clin Dev; 2019 Jun; 13():167-179. PubMed ID: 30788385 [TBL] [Abstract][Full Text] [Related]
5. Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies. Saric A; Andreau K; Armand AS; Møller IM; Petit PX Front Genet; 2015; 6():359. PubMed ID: 26834781 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel mitochondrial localization signals in human Tafazzin, the cause of the inherited cardiomyopathic disorder Barth syndrome. Dinca AA; Chien WM; Chin MT J Mol Cell Cardiol; 2018 Jan; 114():83-92. PubMed ID: 29129703 [TBL] [Abstract][Full Text] [Related]
7. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency. Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924 [TBL] [Abstract][Full Text] [Related]
8. Mis-sesnse mutations in Tafazzin (TAZ) that escort to mild clinical symptoms of Barth syndrome is owed to the minimal inhibitory effect of the mutations on the enzyme function: In-silico evidence. Debnath S; Addya S Interdiscip Sci; 2015 Mar; 7(1):21-35. PubMed ID: 25118650 [TBL] [Abstract][Full Text] [Related]
9. Complex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissues. Lu B; Kelher MR; Lee DP; Lewin TM; Coleman RA; Choy PC; Hatch GM Biochem Cell Biol; 2004 Oct; 82(5):569-76. PubMed ID: 15499385 [TBL] [Abstract][Full Text] [Related]
10. Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy. Hachmann M; Gülcan G; Rajendran R; Höring M; Liebisch G; Bachhuka A; Kohlhaas M; Maack C; Ergün S; Dudek J; Karnati S Front Mol Med; 2024; 4():1389456. PubMed ID: 39086433 [TBL] [Abstract][Full Text] [Related]
11. The enigmatic role of tafazzin in cardiolipin metabolism. Houtkooper RH; Turkenburg M; Poll-The BT; Karall D; Pérez-Cerdá C; Morrone A; Malvagia S; Wanders RJ; Kulik W; Vaz FM Biochim Biophys Acta; 2009 Oct; 1788(10):2003-14. PubMed ID: 19619503 [TBL] [Abstract][Full Text] [Related]
12. Barth Syndrome Cardiomyopathy: An Update. Pang J; Bao Y; Mitchell-Silbaugh K; Veevers J; Fang X Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456462 [TBL] [Abstract][Full Text] [Related]
13. Barth syndrome mutations that cause tafazzin complex lability. Claypool SM; Whited K; Srijumnong S; Han X; Koehler CM J Cell Biol; 2011 Feb; 192(3):447-62. PubMed ID: 21300850 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1. Antunes D; Chowdhury A; Aich A; Saladi S; Harpaz N; Stahl M; Schuldiner M; Herrmann JM; Rehling P; Rapaport D J Mol Med (Berl); 2019 Feb; 97(2):269-279. PubMed ID: 30604168 [TBL] [Abstract][Full Text] [Related]
15. A Drosophila model of Barth syndrome. Xu Y; Condell M; Plesken H; Edelman-Novemsky I; Ma J; Ren M; Schlame M Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11584-8. PubMed ID: 16855048 [TBL] [Abstract][Full Text] [Related]
16. A case of infantile Barth syndrome with severe heart failure: Importance of splicing variants in the TAZ gene. Takeda A; Ueki M; Abe J; Maeta K; Horiguchi T; Yamazawa H; Izumi G; Chida-Nagai A; Sasaki D; Tsujioka T; Sato I; Shiraishi M; Matsuo M Mol Genet Genomic Med; 2023 Jul; 11(7):e2190. PubMed ID: 37186429 [TBL] [Abstract][Full Text] [Related]
17. Phospholipid abnormalities in children with Barth syndrome. Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265 [TBL] [Abstract][Full Text] [Related]
18. AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome. Suzuki-Hatano S; Saha M; Rizzo SA; Witko RL; Gosiker BJ; Ramanathan M; Soustek MS; Jones MD; Kang PB; Byrne BJ; Cade WT; Pacak CA Hum Gene Ther; 2019 Feb; 30(2):139-154. PubMed ID: 30070157 [TBL] [Abstract][Full Text] [Related]
19. Defining functional classes of Barth syndrome mutation in humans. Lu YW; Galbraith L; Herndon JD; Lu YL; Pras-Raves M; Vervaart M; Van Kampen A; Luyf A; Koehler CM; McCaffery JM; Gottlieb E; Vaz FM; Claypool SM Hum Mol Genet; 2016 May; 25(9):1754-70. PubMed ID: 26908608 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomic considerations in the treatment of the pediatric cardiomyopathy called Barth syndrome. Malhotra A; Kahlon P; Donoho T; Doyle IC Recent Pat Biotechnol; 2014; 8(2):136-43. PubMed ID: 25185984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]